Bacterial contamination in cutaneous leishmaniasis: its effect on the lesions' healing course
- PMID: 25814725
- PMCID: PMC4372929
- DOI: 10.4103/0019-5154.152560
Bacterial contamination in cutaneous leishmaniasis: its effect on the lesions' healing course
Abstract
Background: The colonization of aerobic and anaerobic microbial agents on cutaneous leishmaniasis (CL) lesions, especially acute erosive ulcerative ones, has been mentioned in previous studies showing controversial results on the healing course of lesions with the use of antibiotics.
Aims: The purpose of this study was to evaluate the prevalence of secondary bacterial infections in CL lesions and the effect of its elimination on the lesions' improvement rate.
Materials and methods: This cross-sectional clinical trial was performed on 84 acute CL patients. The required skin samples were taken. Cultivation for bacteria was conducted. Patients with positive culture results were divided into two groups. Both groups received standard anti-leishmania treatment, whereas only one group was treated with cephalexin 40-50 mg/kg/day for 10 days. The improvement rate was evaluated in the following visits based on changes in the lesions' induration size.
Results: Among the 84 studied patients, 22.6% had a negative culture result whereas the result was positive in 77.4%. The most common pathogenic germs were Staphylococcus aureus (52.3%) and Staphylococcus epidermidis (9.5%); 34/5% of the positive lesions received antibiotic treatment. Finally, among the lesions with a 75-100% improvement rate, no significant difference was observed between the antibiotic-treated and -untreated groups (36.1% vs. 63.9%, respectively, P = 0.403).
Conclusions: The most common pathogen was S. aureus and, as a primary outcome, the simultaneous treatment for microbial agents did not have any considerable effect on the improvement rate of CL lesions.
Keywords: Acute cutaneous leishmaniasis; aerobe; anaerobe; antibiotic; bacterial colonization.
Conflict of interest statement
Figures
Similar articles
-
Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.Br J Dermatol. 2006 Oct;155(4):680-7. doi: 10.1111/j.1365-2133.2006.07410.x. Br J Dermatol. 2006. PMID: 16965415 Clinical Trial.
-
Leishmania major: bacterial contamination of cutaneous lesions in experimental animals.Isr J Med Sci. 1992 Dec;28(12):847-51. Isr J Med Sci. 1992. PMID: 1286954
-
Isolation of bacteria causing secondary bacterial infection in the lesions of Cutaneous Leishmaniasis.Indian J Dermatol. 2008;53(3):129-31. doi: 10.4103/0019-5154.43217. Indian J Dermatol. 2008. PMID: 19882011 Free PMC article.
-
Distribution frequency of pathogenic bacteria isolated from cutaneus leishmaniasis lesions.Korean J Parasitol. 2008 Sep;46(3):191-3. doi: 10.3347/kjp.2008.46.3.191. Korean J Parasitol. 2008. PMID: 18830062 Free PMC article.
-
Improvements in obtaining New World Leishmania sp from mucosal lesions: notes on isolating and stocking parasites.Exp Parasitol. 2012 Oct;132(2):300-3. doi: 10.1016/j.exppara.2012.06.006. Epub 2012 Jun 21. Exp Parasitol. 2012. PMID: 22728105
Cited by
-
Spectrum of bacterial pathogens in inflammatory and noninflammatory cutaneous ulcers of American tegumentary leishmaniasis.Ther Adv Infect Dis. 2024 Sep 10;11:20499361241274200. doi: 10.1177/20499361241274200. eCollection 2024 Jan-Dec. Ther Adv Infect Dis. 2024. PMID: 39296379 Free PMC article.
-
Pediatric Cutaneous Leishmaniasis: A Clinico-Epidemiological Study from North India.Indian Dermatol Online J. 2021 Nov 22;12(6):852-859. doi: 10.4103/idoj.IDOJ_49_21. eCollection 2021 Nov-Dec. Indian Dermatol Online J. 2021. PMID: 34934721 Free PMC article.
-
Bacterial isolates and drug susceptibility patterns in infected lesions of cutaneous leishmaniasis patients at ALERT hospital, Addis Ababa, Ethiopia.BMC Infect Dis. 2025 Jan 3;25(1):16. doi: 10.1186/s12879-024-10409-w. BMC Infect Dis. 2025. PMID: 39754056 Free PMC article.
-
Cutaneous Leishmaniasis Induces a Transmissible Dysbiotic Skin Microbiota that Promotes Skin Inflammation.Cell Host Microbe. 2017 Jul 12;22(1):13-24.e4. doi: 10.1016/j.chom.2017.06.006. Epub 2017 Jun 29. Cell Host Microbe. 2017. PMID: 28669672 Free PMC article.
-
Prokaryotic and eukaryotic skin microbiota modifications triggered by Leishmania infection in localized Cutaneous Leishmaniasis.PLoS Negl Trop Dis. 2024 Mar 13;18(3):e0012029. doi: 10.1371/journal.pntd.0012029. eCollection 2024 Mar. PLoS Negl Trop Dis. 2024. PMID: 38478569 Free PMC article.
References
-
- Klaus SN, Frankenburg S, Ingber A. Epidemiology of cutaneous leishmaniasis. Clin Dermatol. 1999;17:257–60. - PubMed
-
- Layegh P, Yazdanpanah MJ, Vosugh EM, Pezeshkpoor F, Shakeri MT, Moghiman T. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis. Am J Trop Med Hyg. 2007;77:99–101. - PubMed
-
- AlSamarai AM, AlObaidi HS. Cutaneous leishmaniasis in Iraq. J Infect Dev Ctries. 2009;3:123–9. - PubMed
-
- Shirazi MH, Ranjbar R, Asgari V, Mohebali M, Hamidian M. Study of bacterial infections among the patients with suspected cutaneous leishmaniasis. Pak J Biol Sci. 2007;10:4555–8. - PubMed
LinkOut - more resources
Full Text Sources